SALIX PURPUREA-INJEEL FORTE LIQ (4D,10D,30D,200D/1.1ML) DIN 02066149
Health Canada record
| Active ingredient(s) | PURPLE WILLOW 4 D |
|---|---|
| Dosage form | Liquid |
| Route | Oral |
| Schedule | HOMEOPATHIC |
| Class | Human |
| ATC | |
| Original market date | 31-Dec-1994 |
| Current status date | 22-Jan-1997 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PURPLE WILLOW
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02234105 | SALIX PURPUREA | HOMEOCAN INC. | Granules; Globules; Drops | PURPLE WILLOW 1 X | Cancelled Post Market |
| 01953516 | SALIX PURPUREA GRAN (1CH-30CH) | HOMEOCAN INC. | Tablet | PURPLE WILLOW 1 CH | Cancelled Post Market |
| 02066157 | SALIX PURPUREA-INJEEL LIQ (10D,30D,200D/1.1ML) | BIOLOGISCHE HEILMITTEL HEEL GMBH | Liquid | PURPLE WILLOW 10 D | Cancelled Post Market |